Opexa (OPXA -18%) gets slammed today after posting a Q1 net loss of $0.58 per share, significantly wider than a year-ago, as operating expenses climbed. The company did manage to record $220K in revenue as part of its upfront payments from Merck Serono, versus no revenue during the year-ago quarter. There were no analyst estimates available for comparison.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs